RAPT vs USB · $132.1M cap vs P/E 12, rev $28.66B
RAPT Therapeutics Inc (RAPT) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
RAPT currently screens at market cap $132.1M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the RAPT and USB stock pages for the full models.
Not investment advice.